Research programme: diagnostic and therapeutic agents - Indi Molecular
Alternative Names: Akt PCC; Akt specific branched peptide triligand - Caltech/Integrated Diagnostics; Protein catalysed capture agents - Indi MolecularLatest Information Update: 25 Aug 2023
At a glance
- Originator California Institute of Technology/CalTech; Integrated Diagnostics
- Class Diagnostic agents; Imaging agents; Peptides
- Mechanism of Action Positron-emission tomography enhancers; Proto-oncogene protein c-akt inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 25 Aug 2023 Preclinical development of diagnostic and therapeutic agents is still ongoing for Cancer and Cancer (Diagnosis) in USA
- 28 Dec 2019 No recent reports of development identified for preclinical development in Cancer in USA
- 28 Dec 2019 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in USA